Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.2% on Friday.

Shares of NIKE, Inc. NKE fell sharply in today's pre-market trading following fourth-quarter earnings and soft FY25 guidance.

Analysts at Stifel and Morgan Stanley downgraded the stock following the report.

NIKE shares dipped 15.6% to $79.42 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

Accolade, Inc. ACCD shares tumbled 32.1% to $4.34 in pre-market trading after the company reported first-quarter financial results and issued worse-than-expected FY25 revenue guidance. Also, Needham maintained a Buy rating on the stock but lowered its price target from $13 to $8.
PTC Therapeutics, Inc. PTCT shares slipped 13.5% to $30.00 in pre-market trading after the company said CHMP has issued negative opinion on renewal of conditional marketing authorization of Translarna (Ataluren) for the treatment of nmDMD.
Kura Sushi USA, Inc. KRUS shares declined 12.4% to $72.00 in pre-market trading after the company issued soft guidance.
Rocket Pharmaceuticals, Inc. RCKT shares fell 12.4% to $18.75 in pre-market trading. The company announced the FDA issued a Complete Response Letter for the License Application For KRESLADI and requested limited additional Chemistry Manufacturing and Controls information to complete its review.
Polestar Automotive Holding UK PLC PSNY fell 7.7% to $0.7613 in pre-market trading after the company published full year 2023 results.
Foot Locker, Inc. FL shares fell 5.3% to $24.16 in pre-market trading.
Apellis Pharmaceuticals, Inc. APLS shares declined 4.1% to $39.84 in pre-market trading. Apellis plans to seek re-examination following negative CHMP opinion for pegcetacoplan for geographic atrophy (GA) in the EU.

Don't forget to check out our premarket coverage here